Walmart
HealthBrands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By Ryan HoggNovember 2, 2023
By Chris MorrisNovember 1, 2023
NewslettersWalmart International CEO Kath McLay says her first weeks on the job were like ‘drinking from a firehose’
By Ellie Austin and Joey AbramsOctober 18, 2023
MPWWalmart exec vows to fight inflation: ‘Now is a time where we are more than relevant in consumers’ lives’
By Paige McGlauflinOctober 10, 2023
RetailAmerican consumers are taking their foot off the spending pedal as bargain prices become rarer, former Walmart U.S. CEO says
By Chloe TaylorOctober 10, 2023
RetailOzempic-type drugs are forcing food giants to grapple with less-hungry, less-impulse-prone consumers: ‘This is brand-new territory’
By Leslie Patton and BloombergOctober 7, 2023
HealthFast-food outlets ‘are going to be hurt’ in areas where Ozempic and Wegovy are heavily used, but the selloff in candy and beer stocks is ‘somewhat overdone’
By Lisa Pham, Dasha Afanasieva and BloombergOctober 6, 2023
LifestyleWeight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By Chloe TaylorOctober 5, 2023
HealthWalmart says shoppers taking Ozempic buy ‘slightly less calories’ as retailers brace for the financial consequences of weight-loss drugs
By Brendan Case, Shelly Banjo and BloombergOctober 4, 2023
RetailElon Musk says the shoplifting epidemic is giving him late-stage Roman Empire vibes: ‘America is going full Joker’
By Christiaan HetznerSeptember 27, 2023
FinanceWalmart and Kroger are betting on a bankruptcy-hit indoor farming industry that many consider unsustainable
By Melina Walling, Kendria LaFleur and The Associated PressSeptember 17, 2023
NewslettersIs ‘ESG’ over? GE, Walmart, and Colgate-Palmolive execs on when they do and don’t still use the term
By Sheryl EstradaSeptember 14, 2023
By Christiaan HetznerSeptember 8, 2023
Most Popular
